The major genetic hallmark of CML is the reciprocal chromosomal translocation between chromosomes 9 and 22, which is the Philadelphia chromosome, generating the BCR-ABL1 oncoprotein that exhibits the abnormal tyrosine kinase properties of myeloid cells [3]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.